Incannex website
Web1 day ago · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor ... WebApr 14, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic …
Incannex website
Did you know?
WebApr 14, 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs, is pleased to announce that is has appointed … WebAug 2, 2024 · Incannex Chief Scientific Officer Dr Mark Bleackley said; "Scaling up cGMP manufacture of IHL-216A is an exciting step in the development of our product and represents a critical milestone for ...
Web1 day ago · Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials for the development of CannQuit™ and ReneCann™ products for addiction and immune-disordered skin diseases in the US and EU. IHL is targeting nicotine and opioid addiction with its … WebAug 17, 2024 · Incannex Healthcare Limited. Mr Joel Latham. Managing Director and Chief Executive Officer. +61 409 840 786. [email protected]. Investor Relations Contact – United States. Alyssa Factor ...
WebIncannex Healthcare Limited 1,254 followers on LinkedIn. Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of anxiety disorders, obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung … WebApr 14, 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical …
WebJul 27, 2024 · Incannex Healthcare Limited. Jul 27, 2024, 07:55 ET. MELBOURNE, Australia, July 27, 2024 /PRNewswire/ -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL ...
WebApr 21, 2024 · Website: www.incannex.com.au Investors: [email protected] Forward-looking statements This press release contains "forward-looking statements" within the meaning … easy estatesWebJun 3, 2024 · MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL ), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing... easy essay ioWeb1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs is pleased to announce that is has appointed Quest Pharmaceutical … easy essays topicsWebFeb 28, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of... easyestateWebApr 14, 2024 · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor ... curdridge primary school websiteWebApr 12, 2024 · Incannex Healthcare's mailing address is 13 Central Avenue, Melbourne, Victoria 3189. The official website for the company is impression.healthcare . The … curdridge show 2022WebAug 2, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code "IHL" and also has American Depository Shares listed on NASDAQ under code "IXHL". … easy establishing credit